Canadian Women File Yaz, Yasmin Lawsuit
Date Published: Thursday, March 11th, 2010
Yaz and Yasmin have been named in a lawsuit filed by a group of Canadian women. According to Canadian media reports, the plaintiffs allege that they were not adequately warned about higher than usual risks for stroke and other health problems associated with Yaz and Yasmin.
Yaz and Yasmin are both made with a type of progestin called drospirenone, making them different from many other oral contraceptives. Drospirenone can elevate the body’s potassium levels, which can lead to a condition called hyperkalemia in certain patients. Hyperkalemia may result in potentially serious heart and health problems. Adverse Events reported to the U.S. Food & Drug Administration (FDA) involving Yaz and Yasmin include heart arrhythmias, electrolyte imbalance, hyponatremis, hyperkalemia, hyperkalemic arrhythmias, atrial fibrillation, tachycardia, bradycardia, myocardial infarction, stroke, transient ischemic attack, blood clots, embolisms, and sudden death.
Yasmin and Yaz were approved by Health Canada in 2004 and 2008 respectively, and more than 2 million prescriptions were written for the drugs in Canada last year. According to a report on CTV news, Yaz and Yasmin have been heavily promoted as a contraceptive in Canada that can also help control acne as well as the symptoms of premenstrual syndrome.
The Canadian lawsuit’s statement of claim alleges that Bayer failed to adequately warn patients and doctors about the increased risk of serious adverse injuries associated with use of Yasmin and Yaz as compared to safer oral contraceptives.
In the U.S., Yaz and Yasmin have been named in hundreds of lawsuit filed by women around the country who claim the medications caused them to suffer blood clots, heart attacks, stroke, gallbladder disease and other health problems. On October 1, 2009, all lawsuits involving Yaz and Yasmin currently pending in federal courts were consolidated for centralized and coordinated pre-trial proceedings in the Yasmin and Yaz (Drospirenone) Marketing, Sales Practices and Products Liability Litigation in the United States District Court for the Southern District of Illinois before Judge David R. Herndon (MDL No. 2100). In December, Judge Herndon discussed scheduling a series of “bellwether” trials for the lawsuits, which will serve as a guideline for other cases.
Yaz and Yasmin lawsuits pending in Pennsylvania and New Jersey state courts have also been consolidated.
This entry was posted
on Thursday, March 11th, 2010 at 10:01 am and is filed under Pharmaceuticals, YAZ Birth Control.
Canadian Women File Yaz, Yasmin Lawsuit
Date Published: Thursday, March 11th, 2010
Yaz and Yasmin have been named in a lawsuit filed by a group of Canadian women. According to Canadian media reports, the plaintiffs allege that they were not adequately warned about higher than usual risks for stroke and other health problems associated with Yaz and Yasmin.
Yaz and Yasmin are both made with a type of progestin called drospirenone, making them different from many other oral contraceptives. Drospirenone can elevate the body’s potassium levels, which can lead to a condition called hyperkalemia in certain patients. Hyperkalemia may result in potentially serious heart and health problems. Adverse Events reported to the U.S. Food & Drug Administration (FDA) involving Yaz and Yasmin include heart arrhythmias, electrolyte imbalance, hyponatremis, hyperkalemia, hyperkalemic arrhythmias, atrial fibrillation, tachycardia, bradycardia, myocardial infarction, stroke, transient ischemic attack, blood clots, embolisms, and sudden death.
Yasmin and Yaz were approved by Health Canada in 2004 and 2008 respectively, and more than 2 million prescriptions were written for the drugs in Canada last year. According to a report on CTV news, Yaz and Yasmin have been heavily promoted as a contraceptive in Canada that can also help control acne as well as the symptoms of premenstrual syndrome.
The Canadian lawsuit’s statement of claim alleges that Bayer failed to adequately warn patients and doctors about the increased risk of serious adverse injuries associated with use of Yasmin and Yaz as compared to safer oral contraceptives.
In the U.S., Yaz and Yasmin have been named in hundreds of lawsuit filed by women around the country who claim the medications caused them to suffer blood clots, heart attacks, stroke, gallbladder disease and other health problems. On October 1, 2009, all lawsuits involving Yaz and Yasmin currently pending in federal courts were consolidated for centralized and coordinated pre-trial proceedings in the Yasmin and Yaz (Drospirenone) Marketing, Sales Practices and Products Liability Litigation in the United States District Court for the Southern District of Illinois before Judge David R. Herndon (MDL No. 2100). In December, Judge Herndon discussed scheduling a series of “bellwether” trials for the lawsuits, which will serve as a guideline for other cases.
Yaz and Yasmin lawsuits pending in Pennsylvania and New Jersey state courts have also been consolidated.
<
This entry was posted
on Thursday, March 11th, 2010 at 10:01 am and is filed under Pharmaceuticals, YAZ Birth Control.
You can skip to the end and leave a response. Pinging is currently not allowed.
March 11th, 2010 at 2:54 pm
If I was taking yasmin, how do I join the lawsuit?
March 12th, 2010 at 10:50 am
I have been using Yasmin since June 2006 and have experienced everything from chest pains, tightness in my left arm, heart palpatations, shortness of breath, rage, crying for no reason, depression, lightheadedness, dizziness.
I underwent a stress test at the Montreal Cardiology Cebtre as I thought I had heart problems.
Since the report on CTV I have stopped taking it…
This has caused me much stress…I would like to add my name to the ongoing lawsuit…
Please contact me ASAP as to how I can get get involved.
Thank you,
Adelina Macri